ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

NIH Review Process A Disaster, Borek Says

October 19, 1979

Connie Mack Joins Washington Office Of Shaw Pittman.

March 2, 2001